HTA93 Cost-Effectiveness Analysis of Gemcitabine Nabpaclitaxel Combination, Modified FOLFIRINOX, and SIROX As First-Line Therapy for Pancreatic Cancer
Abstract
Authors
INOUE MAHO Kensuke Moriwaki Kosuke MORIMOTO Kojiro Shimozuma